VANCOUVER, BC – Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company” or “Rakovina Therapeutics”) a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies is pleased… Read More
Depression: One of the Most Common Mental Health Disorders Depression is one of the most prevalent mental health disorders, affecting approximately 280 million people globally. Researchers at Kaunas University of Technology… Read More
OTTAWA, ON — BioTalent Canada proudly announces the release of its National Skills Standard for Cleanroom Readiness, designed to address critical skills shortages in Canadian biomanufacturing. The national skills standard, developed with… Read More
MONREAL, QC – adMare BioInnovations is pleased to announce the spin-out of its Analytical Services Department to Paraza Pharma Inc., a leading contract research organization (CRO) renowned for its expertise… Read More
Wegovy® is the first-and-only medication indicated for both chronic weight management and to reduce the risk of non-fatal myocardial infarction (MI) in Canada.1 Close to one in three Canadian adults… Read More
